<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | simple peptide | Activity</title>
	<link>http://toxicdolls.com/members/peptides658/activity/</link>
	<atom:link href="http://toxicdolls.com/members/peptides658/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for simple peptide.</description>
	<lastBuildDate>Sat, 14 Nov 2026 12:59:33 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">9eea8420dbab1d7f63a3d193ff698146</guid>
				<title>simple peptide posted an update: The pharmaceutical globe has witnessed many innovations, [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/102432/</link>
				<pubDate>Fri, 26 Sep 2025 11:21:46 +0000</pubDate>

									<content:encoded><![CDATA[<p>The pharmaceutical globe has witnessed many innovations, but few have created as much enjoyment as tirzepatide. This novel medication has emerged as some sort of powerful oral treatment option with regard to type 2 diabetes and it has also proven impressive results throughout supporting weight loss. Using rising global issues about obesity in&hellip;<span class="activity-read-more" id="activity-read-more-102432"><a href="http://toxicdolls.com/activity-2/p/102432/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">13d7cb691854d07b9fa6ac194297a087</guid>
				<title>simple peptide became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/102427/</link>
				<pubDate>Fri, 26 Sep 2025 11:19:18 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>